Jacobs Levy Equity Management, Inc Abiomed Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $4.58 Million - $5.66 Million	-15,235 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $3.61 Million - $4.38 Million	11,650 Added 324.97%	15,235 $4.96 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $239,591 - $320,267	-912 Reduced 20.28%	3,585 $1.12 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $1.4 Million - $1.74 Million	-4,889 Reduced 52.09%	4,497 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $11.5 Million - $14.8 Million	-45,506 Reduced 82.9%	9,386 $3.04 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $4.49 Million - $5.58 Million	-17,589 Reduced 24.27%	54,892 $15.2 Million
Q2 2020 Aug 17, 2020	BUY	$141.4 - $257.09 $10.2 Million - $18.6 Million	72,481 New	72,481 $17.5 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $3.6 Million - $5.4 Million	-27,569 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $4.39 Million - $6.16 Million	27,569 New	27,569 $4.7 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $184,950 - $292,316	-658 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $4.09 Million - $5.18 Million	-11,523 Reduced 94.6%	658 $296,000
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $3.67 Million - $5.89 Million	-13,192 Reduced 51.99%	12,181 $4.98 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $1.39 Million - $2.14 Million	-7,218 Reduced 22.15%	25,373 $7.38 Million
Q4 2017 Feb 13, 2018	BUY	$168.78 - $199.74 $2.01 Million - $2.38 Million	11,893 Added 57.46%	32,591 $6.11 Million
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $1.34 Million - $1.55 Million	-9,190 Reduced 30.75%	20,698 $3.49 Million
Q2 2017 Nov 09, 2017	BUY	N/A	29,888	29,888 $4.28 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account